After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of MBX Biosciences Inc is $921.58M. A total of 0.69 million shares were traded on the day, compared to an average of 1.24M shares.
In the most recent transaction, Hawryluk P. Kent bought 20,000 shares of MBX for 13.64 per share on Oct 20 ’25. After the transaction, the President & CEO now owns 468,277 company shares. In a previous transaction on Oct 17 ’25, Hoerter Steven L. bought 20,000 shares at 13.25 per share. MBX shares that Director owns now total 20,000.
Among the insiders who bought shares, Heron Patrick J acquired of 666,666 shares on Sep 26 ’25 at a per-share price of $18.00. This resulted in the Director holding 5,219,440 shares of MBX after the transaction. In another insider transaction, Pescovitz Ora H. bought 7,693 shares at $5.89 per share on Apr 08 ’25. Company shares held by the Director now total 24,329.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, MBX has a high of $27.50 and a low of $4.81.
As of this writing, MBX has an earnings estimate of -$0.66 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of -$0.51 per share and a lower estimate of -$0.78. The company reported an EPS of -$2.78 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MBX is Buy with a score of 4.78.
